Literature DB >> 17706789

Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.

Brian T Terpstra1, Timothy J Collier, Deanna M Marchionini, Nathan D Levine, Katrina L Paumier, Caryl E Sortwell.   

Abstract

The poor survival rate (5-20%) of grafted embryonic dopamine (DA) neurons is one of the primary factors preventing cell replacement from becoming a viable treatment for Parkinson's disease. Previous studies have demonstrated that graft volume impacts grafted DA neuron survival, indicating that transplant parameters influence survival rates. However, the effects of mesencephalic cell concentration on grafted DA neuron survival have not been investigated. The current study compares the survival rates of DA neurons in grafts of varying concentrations. Mesencephalic cell suspensions derived from E14 Fisher 344 rat pups were concentrated to 25,000, 50,000, 100,000 and 200,000 cells/microl and transplanted into two 0.5 microl sites in the 6-OHDA-denervated rat striatum. Animals were sacrificed 10 days and 6 weeks post-transplantation for histochemical analysis of striatal grafts. The absolute number of DA neurons per graft increased proportionally to the total number of cells transplanted. However, our results show that the 200,000 cells/microl group exhibited significantly higher survival rates (5.48+/-0.83%) compared to the 25,000 cells/microl (2.81+/-0.39%) and 50,000 cells/microl (3.36+/-0.51%) groups (p=0.02 and 0.03, respectively). Soma size of grafted DA neurons in the 200,000 cells/microl group was significantly larger than that of the 25,000 cells/microl (p<0.0001) and 50,000 cells/microl groups (p=0.004). In conclusion, increasing the concentration of mesencephalic cells prior to transplantation, augments the survival and functionality of grafted DA neurons. These data have the potential to identify optimal transplantation parameters that can be applied to procedures utilizing stem cells, neural progenitors, and primary mesencephalic cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706789      PMCID: PMC2067253          DOI: 10.1016/j.jneumeth.2007.06.022

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  36 in total

1.  Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.

Authors:  C Rosenblad; A Martinez-Serrano; A Björklund
Journal:  Neuroscience       Date:  1996-12       Impact factor: 3.590

Review 2.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

3.  Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.

Authors:  A C Granholm; J L Mott; K Bowenkamp; S Eken; S Henry; B J Hoffer; P A Lapchak; M R Palmer; C van Horne; G A Gerhardt
Journal:  Exp Brain Res       Date:  1997-08       Impact factor: 1.972

4.  Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease.

Authors:  P Brundin; R E Strecker; O Lindvall; O Isacson; O G Nilsson; G Barbin; A Prochiantz; C Forni; A Nieoullon; H Widner
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 5.  Dopamine cell replacement: Parkinson's disease.

Authors:  D M Yurek; J R Sladek
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

6.  Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.

Authors:  Marco Timmer; Frauke Müller-Ostermeyer; Verena Kloth; Christian Winkler; Claudia Grothe; Guido Nikkhah
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

7.  Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.

Authors:  Deanna M Marchionini; Timothy J Collier; Maria Camargo; Susan McGuire; Mark Pitzer; Caryl E Sortwell
Journal:  J Comp Neurol       Date:  2003-09-15       Impact factor: 3.215

8.  A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.

Authors:  C Warren Olanow; Christopher G Goetz; Jeffrey H Kordower; A Jon Stoessl; Vesna Sossi; Mitchell F Brin; Kathleen M Shannon; G Michael Nauert; Daniel P Perl; James Godbold; Thomas B Freeman
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

9.  BDNF and TrkB expression in intrastriatal ventral mesencephalic grafts in a rat model of Parkinson's disease.

Authors:  J Sautter; M Sabel; C Sommer; S Strecker; N Weidner; W H Oertel; M Kiessling
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

10.  A distinct subset of tenascin/CS-6-PG-rich astrocytes restricts neuronal growth in vitro.

Authors:  S Meiners; E M Powell; H M Geller
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

View more
  6 in total

1.  Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats.

Authors:  Verónica Martínez-Cerdeño; Stephen C Noctor; Ana Espinosa; Jeanelle Ariza; Philip Parker; Samantha Orasji; Marcel M Daadi; Krystof Bankiewicz; Arturo Alvarez-Buylla; Arnold R Kriegstein
Journal:  Cell Stem Cell       Date:  2010-03-05       Impact factor: 24.633

2.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss.

Authors:  A L Spieles-Engemann; M M Behbehani; T J Collier; S L Wohlgenant; K Steece-Collier; K Paumier; B F Daley; S Gombash; L Madhavan; G T Mandybur; J W Lipton; B T Terpstra; C E Sortwell
Journal:  Neurobiol Dis       Date:  2010-03-20       Impact factor: 5.996

3.  Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

Authors:  Timothy J Collier; Jennifer O'Malley; David J Rademacher; Jennifer A Stancati; Kellie A Sisson; Caryl E Sortwell; Katrina L Paumier; Kibrom G Gebremedhin; Kathy Steece-Collier
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

4.  Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrier.

Authors:  Millicent Ford Rauch; Sara Royce Hynes; James Bertram; Andy Redmond; Rebecca Robinson; Cicely Williams; Hao Xu; Joseph A Madri; Erin B Lavik
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

5.  Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures.

Authors:  Marc W Nolte; Wolfgang Löscher; Christiane Herden; William J Freed; Manuela Gernert
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

6.  Cell therapy for Parkinson's disease: Why it doesn't work every time.

Authors:  Timothy J Collier; Caryl E Sortwell; Natosha M Mercado; Kathy Steece-Collier
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.